Ute Scholz

892 total citations
33 papers, 390 citations indexed

About

Ute Scholz is a scholar working on Hematology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ute Scholz has authored 33 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 10 papers in Genetics and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ute Scholz's work include Hemophilia Treatment and Research (16 papers), Platelet Disorders and Treatments (12 papers) and Blood Coagulation and Thrombosis Mechanisms (12 papers). Ute Scholz is often cited by papers focused on Hemophilia Treatment and Research (16 papers), Platelet Disorders and Treatments (12 papers) and Blood Coagulation and Thrombosis Mechanisms (12 papers). Ute Scholz collaborates with scholars based in Germany, Austria and United States. Ute Scholz's co-authors include A. Siegemund, T. Siegemund, Lothar Engelmann, Sirak Petros, Rupert Bauersachs, Rainer B. Zotz, Birgit Linnemann, Hannelore Rott, Susan Halimeh and Bettina Tóth and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Molecular Sciences.

In The Last Decade

Ute Scholz

27 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ute Scholz Germany 12 245 136 130 84 48 33 390
Anne F. Klenner Germany 6 235 1.0× 50 0.4× 86 0.7× 96 1.1× 35 0.7× 13 384
Johan Holm Sweden 11 216 0.9× 274 2.0× 133 1.0× 95 1.1× 68 1.4× 21 507
Emilia Parodi Italy 10 165 0.7× 27 0.2× 19 0.1× 51 0.6× 49 1.0× 28 268
Kristine Robinson United States 6 257 1.0× 217 1.6× 292 2.2× 88 1.0× 10 0.2× 8 415
A. Thomas United States 7 110 0.4× 159 1.2× 37 0.3× 45 0.5× 23 0.5× 12 338
D. BERGQVIST Sweden 10 94 0.4× 259 1.9× 364 2.8× 216 2.6× 9 0.2× 19 529
A Derlon France 13 235 1.0× 104 0.8× 138 1.1× 180 2.1× 32 0.7× 28 444
Hannelore Rott Germany 10 159 0.6× 88 0.6× 110 0.8× 29 0.3× 13 0.3× 16 261
Garrett B. Wong United States 7 43 0.2× 153 1.1× 50 0.4× 154 1.8× 10 0.2× 14 322
S. Rammos Germany 13 30 0.1× 175 1.3× 36 0.3× 177 2.1× 10 0.2× 25 460

Countries citing papers authored by Ute Scholz

Since Specialization
Citations

This map shows the geographic impact of Ute Scholz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ute Scholz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ute Scholz more than expected).

Fields of papers citing papers by Ute Scholz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ute Scholz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ute Scholz. The network helps show where Ute Scholz may publish in the future.

Co-authorship network of co-authors of Ute Scholz

This figure shows the co-authorship network connecting the top 25 collaborators of Ute Scholz. A scholar is included among the top collaborators of Ute Scholz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ute Scholz. Ute Scholz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Müller, Jens, et al.. (2025). Laboratory Monitoring in Patients Receiving Emicizumab. Hämostaseologie. 1 indexed citations
3.
Halimeh, Susan, Behnaz Pezeshkpoor, Jens Müller, et al.. (2025). Landscape and Spectrum of VWF Variants in Type 2 Von Willebrand Disease: Insights from a German Patient Cohort. Thrombosis and Haemostasis. 126(2). 156–178. 1 indexed citations
4.
Pezeshkpoor, Behnaz, Heiko Rühl, Vytautas Ivaškevičius, et al.. (2024). Genetic Landscape of Factor VII Deficiency: Insights from a Comprehensive Analysis of Pathogenic Variants and Their Impact on Coagulation Activity. International Journal of Molecular Sciences. 25(4). 2384–2384.
5.
Pezeshkpoor, Behnaz, Jens Müller, Bernd Pötzsch, et al.. (2024). Unravelling the spectrum of von Willebrand factor variants in quantitative von Willebrand disease: results from a German cohort study. Journal of Thrombosis and Haemostasis. 22(11). 3010–3034. 4 indexed citations
6.
Vicent, O., Jan Beyer‐Westendorf, Oliver Tiebel, et al.. (2022). Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a retrospective study. Thrombosis Journal. 20(1). 48–48. 11 indexed citations
7.
Kaiser, Thorsten, Ute Scholz, Christian Pfrepper, et al.. (2022). Influencing Factors and Differences in Born Aggregometry in Specialized Hemostaseological Centers: Results of a Multicenter Laboratory Comparison. SHILAP Revista de lepidopterología. 6(3). e213–e220. 2 indexed citations
8.
Müller, Jens, et al.. (2022). Reference Intervals in Coagulation Analysis. Hämostaseologie. 42(6). 381–389. 1 indexed citations
9.
Dieterlen, Maja‐Theresa, Sandra Eifert, Ute Scholz, et al.. (2021). Device‐induced platelet dysfunction in patients after left ventricular assist device implantation. Journal of Thrombosis and Haemostasis. 19(5). 1331–1341. 19 indexed citations
10.
Escuriola‐Ettingshausen, C., Günter Auerswald, Christoph Königs, et al.. (2020). Optimizing the management of patients with haemophilia A and inhibitors in the era of emicizumab: Recommendations from a German expert panel. Haemophilia. 27(3). e305–e313. 28 indexed citations
11.
Dieterlen, Maja‐Theresa, Ute Scholz, Sven Lehmann, et al.. (2019). Acquired von Willebrand factor deficiency is reduced in HeartMate 3 patients†. European Journal of Cardio-Thoracic Surgery. 56(3). 444–450. 16 indexed citations
12.
Tiefenbacher, Stefan, Manuela Albisetti, Peter R. Baker, et al.. (2019). Estimation of Nuwiq®(simoctocog alfa) activity using one‐stage and chromogenic assays—Results from an international comparative field study. Haemophilia. 25(4). 708–717. 5 indexed citations
13.
Schilling, Kristina, Robert Klamroth, Karim Kentouche, et al.. (2019). Development of Haemophilia Treatment in the Eastern Part of Germany over the Last Decade in the Kompetenznetz Hämorrhagische Diathese Ost (KHDO). Hämostaseologie. 40(1). 119–127. 3 indexed citations
14.
Holstein, Katharina, Paul Knöbl, Christiane Dobbelstein, et al.. (2017). Factor VIII Activity and Risk of Bleeding in Acquired Hemophilia a: Results from the Gth-AH 01/2010 Study. Blood. 130. 22–22. 2 indexed citations
15.
Pfrepper, Christian, et al.. (2016). Prophylactic treatment of hereditary severe factor VII deficiency in pregnancy. Blood Coagulation & Fibrinolysis. 28(6). 490–492. 8 indexed citations
16.
Tiede, Andreas, Robert Klamroth, S. Gottstein, et al.. (2013). Prognostic Parameters For Remission Of and Survival In Acquired Hemophilia A: Results Of The GTH-AH 01/2010 Multicenter Study. Blood. 122(21). 205–205. 1 indexed citations
17.
Desch, Steffen, A. Siegemund, Ute Scholz, et al.. (2011). Platelet inhibition and GP IIb/IIIa receptor occupancy by intracoronary versus intravenous bolus administration of abciximab in patients with ST-elevation myocardial infarction. Clinical Research in Cardiology. 101(2). 117–124. 27 indexed citations
18.
Siegemund, A., Sirak Petros, T. Siegemund, et al.. (2004). The endogenous thrombin potential and high levels of coagulation factor VIII, factor IX and factor XI. Blood Coagulation & Fibrinolysis. 15(3). 241–244. 27 indexed citations
19.
Siegemund, T., A. Siegemund, Ute Scholz, Lothar Engelmann, & Sirak Petros. (2003). Thrombin generation in severe haemophilia A and B: the endogenous thrombin potential in platelet-rich plasma. Thrombosis and Haemostasis. 90(11). 781–786. 60 indexed citations
20.
Kohl, J., et al.. (1992). Discharge of pulmonary rapidly adapting stretch receptors during HFO ventilation. Respiration Physiology. 90(1). 115–124. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne F. Klenner Breakdown of academic impact, for papers by Johan Holm Breakdown of academic impact, for papers by Emilia Parodi Breakdown of academic impact, for papers by Kristine Robinson Breakdown of academic impact, for papers by A. Thomas Breakdown of academic impact, for papers by D. BERGQVIST Breakdown of academic impact, for papers by A Derlon Breakdown of academic impact, for papers by Hannelore Rott Breakdown of academic impact, for papers by Garrett B. Wong Breakdown of academic impact, for papers by S. Rammos
Rankless by CCL
2026